loading

Finanzdaten der Pieris Pharmaceuticals Inc-Aktie (PIRS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
95.92%
0.053
1.299 19.52 20.05 1.936
Operating Expenses
7.66%
5.356
5.80 31.33 17.99 17.45
Benefits Costs and Expenses
100.00%
-
67.35 - - -
Costs And Expenses
810.88%
5.356
0.588 31.33 17.99 17.45
Operating Income/Loss
17.82%
-5.303
-4.501 -11.81 2.063 -15.51
Income/Loss From Continuing Operations Before Tax
100.08%
0.053
-66.06 19.52 20.05 1.936
Income/Loss From Continuing Operations After Tax
6.70%
-4.892
-4.585 -10.75 3.976 -13.18
Net Income/Loss
6.72%
-4.892
-4.584 -10.75 3.976 -13.18
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
58.36%
1.237
2.971 98.85 87.64 74.52
Basic Earnings Per Share
9,775%
-3.95
-0.04 -0.11 0.05 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.36
price down icon 1.17%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$189.49
price down icon 1.81%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):